Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma
Clinical trial NCT00077285 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00077285
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2027-10-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.